Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Canine IL-31 Protein
SDP

Catalog No. p-7111085 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
250 μg
50 μg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP25959150 50 μg
NBP259591Y 250 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. NBP25959150 Supplier Novus Biologicals™ Supplier No. NBP25959150UG
Only null left
Add to Cart
Add to Cart

Highly purified. Generating reliable and reproducible results. Applications: SDS-Page

A recombinant protein with a C-Terminal His-tag and corresponding to the amino acids 24-159 of Canine IL-31 The Recombinant Canine IL-31 Protein is derived from Baculovirus. The Recombinant Canine IL-31 Protein has been validated for the following applications: SDS-Page.

Specifications

Concentration 1mg/mL
For Use With (Application) SDS-PAGE
Formulation Liquid. PBS (pH 7.4) containing 10% glycerol
Gene ID (Entrez) 386653
Molecular Weight (g/mol) 16.1 kDa
Name Recombinant Canine IL-31 Protein
Purification Method >90%, by SDS-PAGE
Quantity 50 μg
Source Baculovirus
Storage Requirements Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
Regulatory Status RUO
Endotoxin Concentration <1.0 EU per 1μg of protein (determined by LAL method)
Gene Alias IL-31interleukin-31, interleukin 31
Gene Symbol IL31
Product Type Recombinant Protein
Conjugate Unconjugated
Cross Reactivity Canine
Recombinant Recombinant
Show More Show Less

For Research Use Only.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.